The 4th In Vivo Cell Engineering & Gene Editing Summit, taking place June 3–5, 2025 in Boston, is the definitive event ...

The 6th Gene Therapy Analytical Development Summit Europe, taking place from 20 th – 22 nd May 2025 in London, returns as the only European forum solely dedicated to tackling the analytical and ...

According to its backers, MAGIC-I is Ireland's first clinical study of its type in cancer care and will harness "the power of ...

There is currently no approved treatment for intracerebral haemorrhagic (ICH) stroke, but Belgian startup Bioxodes hopes to ...

Roche has said it is petitioning the Trump administration for an exemption from threatened tariffs for pharmaceuticals, ...

AstraZeneca has started work with tech companies Tempus and Pathos AI on a project that aims to generate a wide-ranging and ...

As a psychiatric provider working with people from all walks of life, I’ve seen how serious mental health conditions, ...

Women are being overlooked in the UK's HIV response and can face barriers to accessing prevention, testing, and care, ...

Accurate KOL data is essential for ensuring that commercial and medical teams reach the right healthcare professionals (HCPs) ...

These have been dark days for the global economy, and the short-term prospects for the pharmaceutical industry look uncertain. The industry is currently undergoing change and restructuring on an ...

GSK has reported much-needed progress with two of its cancer therapies, with a phase 3 trial win for immunotherapy Jemperli in endometrial cancer and the start of a review in the EU for ...

Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...